Global Search | Novartis

Sort by

Relevance

Newest first

Oldest first

Hide Filters

Showing 1672 results

Media Library / Mar 01, 2024

Quality control for environmental monitoring in radioligand therapy (RLT) manufacturing
Media Library / Mar 01, 2024

Specialized equipment for the manufacture of radioligand therapy (RLT)
Statement / Aug 15, 2024

Novartis statement on Maximum Fair Price for Entresto
Pulse Update / May 10, 2024

Novartis receives FDA Breakthrough Therapy designation for Scemblix® in 1L CML
Story / Nov 21, 2024

Addressing unmet needs for inherited neuromuscular diseases

Discovery

Novartis has acquired Kate Therapeutics to further enhance and strengthen our ongoing efforts to advance gene therapies for patients.
Pulse Update / Dec 02, 2024

Novartis bolsters Neuroscience pipeline with in-licensing of PTC518 for Huntington’s disease
Clinical Trials / Jun 22, 2025

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
Clinical Trials / Dec 01, 2025

A Multi-center, Ambispective Cohort Study to Evaluate the Impact of Iptacopan for Adult Patients With PNH in China
Clinical Trials / Dec 23, 2025

RWE,NIS,Prospective Study for the Effectiveness, Tolerability and Adherence of Asciminib in Saudi Arabia. (ASC4REAL)
Clinical Trials / Feb 17, 2026

Modifying PEST for Psoriatic Arthritis Screening

‹ Previous page
1
…
56
57
58
59
60
61
62
…
168
› Next page